Biosimilars create chances to improve sustainability and affordability of cancer treatmen
Biosimilars create opportunities for sustainable cancer care, says the European Society for Medical Oncology (ESMO) in a position paper published ...
Biosimilars create opportunities for sustainable cancer care, says the European Society for Medical Oncology (ESMO) in a position paper published ...
Two of the biosimilars—trastuzumab and pegfilgrastim—are under review by drug regulator European Medicines Agency. Photo: Hemant Mishra/Mint Hyderabad: Bio-pharmaceutical company ...
© 2023 HealthTopical - Premium WordPress news & magazine theme by HealthTopical.
© 2023 HealthTopical - Premium WordPress news & magazine theme by HealthTopical.